25 patents
Page 2 of 2
Utility
Methods of Treating Ophthalmic Disease/disorder or Injury with Ibudilast
22 Apr 20
This disclosure is directed to methods of treating ophthalmic disease/disorder or injury associated with neurodegenerative disease/disorder, such as progressive multiple sclerosis, or a neuro-ophthalmologic disorder in human patients using ibudilast.
Kazuko Matsuda
Filed: 17 Oct 19
Utility
Combination of Ibudilast and Interferon-beta and Methods of Using Same
8 Apr 20
This disclosure is directed to methods of alleviating the negative effects of, treating, or slowing the progression of progressive multiple sclerosis in human patients using ibudilast and interferon-beta.
Kazuko MATSUDA
Filed: 7 Oct 19
Utility
Treatment of Progressive Neurodegenerative Disease with Ibudilast
25 Mar 20
Compositions and methods for treating progressive neurodegenerative diseases, and their associated symptoms by administration of ibudilast (3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine).
Michael E. KALAFER, Kenneth W. LOCKE, Kazuko MATSUDA, Richard E. GAMMANS
Filed: 30 Apr 19
Utility
Methods of Treating Glioblastoma Multiforme Using Ibudilast
5 Feb 20
Compositions and methods for treating glioblastoma or recurrent glioblastoma and its associated symptoms by administration of ibudilast (3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine) or a pharmaceutically acceptable salt thereof.
Kazuko Matsuda, Kerrie McDonald
Filed: 8 Jul 19
Utility
Combination of Ibudilast and Riluzole and Methods of Using Same
29 Jan 20
The present disclosure relates generally to methods for treating neurodegenerative diseases, including their progressive forms.
Kazuko Matsuda, Yuichi Iwaki
Filed: 27 Feb 19